Standard BioTools Gross Margin 2010-2023 | LAB
Current and historical gross margin for Standard BioTools (LAB) over the last 10 years. The current gross profit margin for Standard BioTools as of December 31, 2023 is %.
| Standard BioTools Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $0.11B | $0.05B | 48.11% |
| 2023-09-30 | $0.11B | $0.05B | 45.71% |
| 2023-06-30 | $0.11B | $0.05B | 43.40% |
| 2023-03-31 | $0.10B | $0.04B | 37.11% |
| 2022-12-31 | $0.10B | $0.04B | 36.36% |
| 2022-09-30 | $0.11B | $0.05B | 40.91% |
| 2022-06-30 | $0.11B | $0.05B | 44.25% |
| 2022-03-31 | $0.13B | $0.06B | 49.60% |
| 2021-12-31 | $0.13B | $0.07B | 52.67% |
| 2021-09-30 | $0.14B | $0.08B | 54.35% |
| 2021-06-30 | $0.15B | $0.09B | 57.72% |
| 2021-03-31 | $0.14B | $0.09B | 59.03% |
| 2020-12-31 | $0.14B | $0.08B | 58.99% |
| 2020-09-30 | $0.13B | $0.07B | 58.73% |
| 2020-06-30 | $0.11B | $0.06B | 56.25% |
| 2020-03-31 | $0.11B | $0.06B | 55.26% |
| 2019-12-31 | $0.12B | $0.06B | 55.17% |
| 2019-09-30 | $0.12B | $0.07B | 56.03% |
| 2019-06-30 | $0.12B | $0.07B | 56.30% |
| 2019-03-31 | $0.12B | $0.07B | 56.41% |
| 2018-12-31 | $0.11B | $0.06B | 55.36% |
| 2018-09-30 | $0.11B | $0.06B | 52.78% |
| 2018-06-30 | $0.10B | $0.05B | 50.96% |
| 2018-03-31 | $0.10B | $0.05B | 50.00% |
| 2017-12-31 | $0.10B | $0.05B | 50.49% |
| 2017-09-30 | $0.10B | $0.05B | 52.00% |
| 2017-06-30 | $0.10B | $0.05B | 53.61% |
| 2017-03-31 | $0.10B | $0.06B | 55.45% |
| 2016-12-31 | $0.10B | $0.06B | 56.73% |
| 2016-09-30 | $0.11B | $0.06B | 57.27% |
| 2016-06-30 | $0.12B | $0.07B | 58.12% |
| 2016-03-31 | $0.12B | $0.07B | 58.47% |
| 2015-12-31 | $0.12B | $0.07B | 58.62% |
| 2015-09-30 | $0.12B | $0.07B | 60.17% |
| 2015-06-30 | $0.12B | $0.07B | 60.50% |
| 2015-03-31 | $0.12B | $0.07B | 61.86% |
| 2014-12-31 | $0.12B | $0.07B | 63.25% |
| 2014-09-30 | $0.11B | $0.07B | 64.76% |
| 2014-06-30 | $0.09B | $0.06B | 67.74% |
| 2014-03-31 | $0.08B | $0.06B | 70.73% |
| 2013-12-31 | $0.07B | $0.05B | 71.83% |
| 2013-09-30 | $0.07B | $0.05B | 71.21% |
| 2013-06-30 | $0.06B | $0.04B | 70.49% |
| 2013-03-31 | $0.06B | $0.04B | 68.42% |
| 2012-12-31 | $0.05B | $0.04B | 67.92% |
| 2012-09-30 | $0.05B | $0.03B | 68.00% |
| 2012-06-30 | $0.05B | $0.03B | 66.67% |
| 2012-03-31 | $0.05B | $0.03B | 67.39% |
| 2011-12-31 | $0.04B | $0.03B | 68.18% |
| 2011-09-30 | $0.04B | $0.03B | 68.29% |
| 2011-06-30 | $0.04B | $0.03B | 71.05% |
| 2011-03-31 | $0.04B | $0.02B | 68.57% |
| 2010-12-31 | $0.03B | $0.02B | 66.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.708B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
| Inspire Medical Systems (INSP) | United States | $7.194B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.483B | 0.00 |
| Axonics (AXNX) | United States | $3.401B | 0.00 |
| 10x Genomics (TXG) | United States | $3.288B | 0.00 |
| Enovis (ENOV) | United States | $3.030B | 23.02 |
| Azenta (AZTA) | United States | $2.910B | 237.18 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.678B | 0.00 |
| Privia Health (PRVA) | United States | $2.167B | 96.11 |
| Schrodinger (SDGR) | United States | $1.733B | 0.00 |
| Omnicell (OMCL) | United States | $1.279B | 31.30 |
| Phreesia (PHR) | United States | $1.162B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.153B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
| Augmedix (AUGX) | United States | $0.139B | 0.00 |
| Outset Medical (OM) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.03 |
| 111 (YI) | China | $0.086B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |